graph EGM comparisons
atezolizumab plus carboplatin plus nab-paclitaxeltitlecarboplatin plus nab-paclitaxeltitleIMpower-130 (all population), 2019 NCT02367781 non squamous - mNSCLC - L1 - all population 483/240IMpower-130 (WT), 2019 NCT02367781 non squamous - mNSCLC - L1 - Wild Type (WT) 451/228

Pathology:  non squamous - mNSCLC - L1 - all population;   non squamous - mNSCLC - L1 - Wild Type (WT); 

non squamous - mNSCLC - L1 - all populationnon squamous - mNSCLC - L1 - Wild Type (WT)
IMpower-130 (all population), 2019IMpower-130 (WT), 2019
atezolizumab plus carboplatin plus nab-paclitaxel2T1T0T1
carboplatin plus nab-paclitaxel0T0